01477.HK
Ocumension Therapeutics
HKSE · Healthcare · Biotechnology · CN
HKD 5.10
−4.77%Next report
Analyst consensus
- Next report date
- Mar 19, 2027
- EPS estimate
- HKD 0.05
- Revenue estimate
- HKD 750.9M
Latest reported
- Last report date
- Aug 28, 2026
- EPS actual
- -HKD 0.14
- EPS estimate
- -HKD 0.03
- Revenue actual
- HKD 488.8M
- Revenue estimate
- HKD 545.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -300.0%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 28, 2026 | -HKD 0.03 | -HKD 0.14 | Miss -299.97% | HKD 488.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 19, 2027